Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France
  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    1 1
    Investigated drugs:
    Belgium Denmark France Italy Spain
  • Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    1 1
    Investigated drugs:
    Italy Spain
  • Study on Atezolizumab for Patients with Locally Advanced Cervical Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer

    Not recruiting

    1 1 1
    France Germany Italy The Netherlands Spain
  • Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Czechia Ireland Italy The Netherlands Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Belgium Spain
  • Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +6